Optical Spectroscopy During Breast Cancer Surgery and Core Needle Biopsy
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Breast Cancer
- Sponsor
- Duke University
- Enrollment
- 213
- Locations
- 1
- Primary Endpoint
- Optical signatures
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
The objective of the proposed research is to develop new diagnostic modalities based on optical spectroscopy (auto fluorescence, absorption, and scattering) for the diagnosis of breast cancer and test its performance as an adjunct to core needle biopsy. For the surgery part of the study, all patients scheduled to have a mastectomy or lumpectomy for the treatment of breast cancer will be asked if they would be willing to participate in this study. For the core needle biopsy part of the study, patients with a higher pre-probability of cancer (based on mammography) will be recruited to increase the number of patients with malignant lesions and enrolled in this investigation.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients having a needle biopsy of a breast mass
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Optical signatures
Time Frame: Day of procedure (less than 10 minutes)
The primary outcome of this study is the identification of the optical signatures of normal and cancerous tissue of the breast